Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Absolute Coronary Flow in Patients With Heart Failure With Reduced Ejection Fraction and Left Bundle Branch Block With Cardiac Resynchronization Therapy

NCT05564689 is registered in ClinicalTrials.gov with Ashkan Eftekhari as lead sponsor.

NCT NCT05564689
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05564689 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Absolute Coronary Flow in Patients With Heart Failure With Reduced Ejection Fraction and Left Bundle Branch Block With Cardiac Resynchronization Therapy
Lead sponsor
Ashkan Eftekhari
Phase
Observational
Overall status
Recruiting
Start date
September 29, 2022
Completion date
September 30, 2026
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac resynchronization therapy, dilated cardiomyopathy, heart failure, left bundle-branch block